|
|
Volumn 36, Issue 29, 2015, Pages 1842-1843
|
|
Cardiovascular precision medicine: Hope or hype?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
HYDRALAZINE PLUS ISOSORBIDE DINITRATE;
NITRIC OXIDE;
PLACEBO;
POTASSIUM CHANNEL KCNQ1;
PRAZOSIN;
SODIUM CHANNEL NAV1.5;
ANTICOAGULANT THERAPY;
ATRIAL FIBRILLATION;
BIOAVAILABILITY;
CARDIOVASCULAR MORTALITY;
CARDIOVASCULAR PRECISION MEDICINE;
CLINICAL TRIAL (TOPIC);
CORONARY ARTERY DISEASE;
GENE LOCUS;
GENE MUTATION;
GENETIC VARIABILITY;
GENOTYPE PHENOTYPE CORRELATION;
HEART FAILURE;
HUMAN;
HYPERTENSION;
LONG QT SYNDROME;
MEDICINE;
MISSENSE MUTATION;
NOTE;
PRIORITY JOURNAL;
SURVIVAL;
THROMBOEMBOLISM;
CARDIOVASCULAR DISEASES;
FORECASTING;
PERSONALIZED MEDICINE;
TRENDS;
CARDIOVASCULAR DISEASES;
FORECASTING;
HUMANS;
PRECISION MEDICINE;
|
|
EID: 84939542491
PISSN: 0195668X
EISSN: 15229645
Source Type: Journal
DOI: 10.1093/eurheartj/ehv226 Document Type: Note |
|
Times cited : (15)
|
|
References (0)
|
